Are these physiological diseases almost unique to us Chinese? Do you really need to know? Today, relevant experts will take us to find out. From an epidemiological perspective, from history to the present, the most prominent infectious disease in China is actually not SARS or AIDS, but hepatitis B.
In the past, due to the imperfect public health system in our country, irregular blood transfusions, unsafe injections and other related reasons, those born in the 1960s to 1980s had a very high risk of death. Hepatitis B infection rate.
Previous studies have shown that during the period from 1957 to 1989, the probability of hepatitis B infection in China reached an unprecedented 14%; even today when hepatitis B vaccine is widely available.
There are still nearly 100 million hepatitis B patients in our country. Since there is currently no way to cure hepatitis B, the chronic hepatitis that evolves may greatly increase the incidence of liver cancer, which will have a serious impact. The overall health of our people is also a haze that we in China have been facing for decades.
Our country has invested countless money and manpower in trying to save those patients who have been infected with hepatitis B, but we are really powerless.
But after so many years of hard work, it has dropped from red (gt; 8) to about 6. However, our country still has the largest number of hepatitis B patients in the world.
So much so that every Chinese person is terrified when mentioning the "big three yangs" and "small three yangs". People's knowledge of diseases is always more inclined to "treatment".
However, as “the best medicine can cure the disease,” in the field of medicine, prevention is always the most cost-effective method. I hope that everyone will always remember China as a “big country with hepatitis B”.
Always remind yourself of the importance of disease prevention. Those who clamor not to get vaccinated, or those who do not get vaccinated because of vaccine incidents, are either stupid or bad.
Of course there is drug-induced liver injury (Drug-induced liver injury, DILI). In fact, drug-induced liver injury is not a relatively rare disease worldwide. It itself is one of the main side effects caused by Western medicine, and it is also a reason why most modern drug clinical trials fail.
But liver damage caused by traditional Chinese medicine can be regarded as a disease unique to China. The most important thing is that its harm is far underestimated.
And it is not until the past few years that our Chinese scholars have begun to pay attention to this research. In recent years, reports on aristolochic acid causing liver cancer published in the Science sub-journal "Science Translation Medicine" only revealed that aristolochic acid causes liver cancer. A beginning of prescribing traditional Chinese medicine for hepatotoxicity.
The article stated that 78% of liver cancer cases in Taiwan and 47% in mainland China are related to aristolochic acid and its derivatives. Although the specific number is still controversial, and aristolochic acid is How much role it plays in the development of liver cancer is still unknown.
But the damage caused by aristolochic acid and its derivatives to liver cells is real. If long-term use of some traditional Chinese medicines may cause liver cancer, people and regulatory authorities have paid attention to it. Drug-induced liver injury caused by traditional Chinese medicines is more acute, and it is more difficult to characterize.
In early 2019, a paper published by Shanghai Jiao Tong University in Gastroenterology began to systematically evaluate drug-induced liver injury caused by traditional Chinese medicine on a large scale.
The article counted nearly 26,000 cases of drug-induced liver injury in 308 medical institutions between 2012 and 2014. It was found that drug-induced liver injury caused by traditional Chinese medicine or health products accounted for all DILI 26.81 for cases, higher than 21.99 for anti-tuberculosis drugs.
If we make another disease distinction for liver damage, we may find that 40.3% of DILI in patients with skin diseases and geriatric diseases is caused by traditional Chinese medicine.
In fact, this is not a disease unique to China. The entire Asian region that is radiated by Chinese culture, including South Korea, Japan, and Singapore, is suffering from liver damage caused by traditional Chinese medicine and herbal medicine. of the hardest hit areas. But what we want to emphasize is that liver injury induced by traditional Chinese medicine is far underestimated in our country.
After the publication of an article in 2019, supporters of traditional Chinese medicine claimed that "only" 26.8% of DILI was caused by traditional Chinese medicine and health care products, and more than 70% of the other DILI was caused by western medicine, so traditional Chinese medicine is safer than western medicine.
However, the liver toxicity of Western medicine has been widely studied and can be expected. Traditional Chinese medicines, including Panax notoginseng, Tripterygium wilfordii, Huang Yaozi, mugwort leaf, Ginkgo biloba, Polygonum multiflorum, Psoralen, Corydalis corydalis, rhubarb, Cassia seed, Aconite and other commonly used traditional Chinese medicines, although hepatotoxicity has been reported,
However, its toxicological research is relatively lacking, coupled with its complex ingredients and the combination of Chinese and Western medicine. As a result, many avoidable traditional Chinese medicine-induced liver injuries occur every day. In addition, kidney damage caused by traditional Chinese medicine may also be one of the unique diseases in China.